318 related articles for article (PubMed ID: 29879429)
1. Increase of SOX9 promotes hepatic ischemia/reperfusion (IR) injury by activating TGF-β1.
Fan XD; Zheng HB; Fan XS; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(1):215-221. PubMed ID: 29879429
[TBL] [Abstract][Full Text] [Related]
2. STIM1 deficiency protects the liver from ischemia/reperfusion injury in mice.
Li Y; Lou C; Wang W
Biochem Biophys Res Commun; 2018 Feb; 496(2):422-428. PubMed ID: 29305862
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice.
Takeuchi D; Yoshidome H; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Morita Y; Miyazaki M
Hepatology; 2004 Mar; 39(3):699-710. PubMed ID: 14999688
[TBL] [Abstract][Full Text] [Related]
4. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
[TBL] [Abstract][Full Text] [Related]
5. MTMR14 protects against hepatic ischemia-reperfusion injury through interacting with AKT signaling in vivo and in vitro.
Li S; Zhang M; Zhang B
Biomed Pharmacother; 2020 Sep; 129():110455. PubMed ID: 32768948
[TBL] [Abstract][Full Text] [Related]
6. Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl
Ji DG; Zhang Y; Yao SM; Zhai XJ; Zhang LR; Zhang YZ; Li H
Biomed Pharmacother; 2018 Jun; 102():26-33. PubMed ID: 29549726
[TBL] [Abstract][Full Text] [Related]
7. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.
Hou J; Xia Y; Jiang R; Chen D; Xu J; Deng L; Huang X; Wang X; Sun B
J Hepatol; 2014 Feb; 60(2):306-12. PubMed ID: 24128416
[TBL] [Abstract][Full Text] [Related]
8. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
9. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice.
Yang H; Zhou H; Zhuang L; Auwerx J; Schoonjans K; Wang X; Feng C; Lu L
Liver Transpl; 2017 Jan; 23(1):63-74. PubMed ID: 27597295
[TBL] [Abstract][Full Text] [Related]
10. TNIP1 alleviates hepatic ischemia/reperfusion injury via the TLR2-Myd88 pathway.
Zhang Y; Lei X; Li W; Ding X; Bai J; Wang J; Wu G
Biochem Biophys Res Commun; 2018 Jun; 501(1):186-192. PubMed ID: 29709475
[TBL] [Abstract][Full Text] [Related]
11. [Maresin1 inhibits the NF-κB/caspase-3/GSDME signaling pathway to alleviate hepatic ischemia-reperfusion injury].
Zeng HS; Wang YB; Chen LXZ; Zhu P
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):594-600. PubMed ID: 37400383
[No Abstract] [Full Text] [Related]
12. NR4A1 knockdown confers hepatoprotection against ischaemia-reperfusion injury by suppressing TGFβ1 via inhibition of CYR61/NF-κB in mouse hepatocytes.
Cao J; Xu T; Zhou C; Wang S; Jiang B; Wu K; Ma L
J Cell Mol Med; 2021 Jun; 25(11):5099-5112. PubMed ID: 33942481
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice.
Chen Z; Ding T; Ma CG
Biochem Biophys Res Commun; 2017 Nov; 493(2):1143-1150. PubMed ID: 28784305
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo.
He D; Guo Z; Pu JL; Zheng DF; Wei XF; Liu R; Tang CY; Wu ZJ
Int Immunopharmacol; 2016 Jun; 35():201-209. PubMed ID: 27064547
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific overactivation of nuclear erythroid 2 p45-related factor 2-mediated gene expression in myeloid cells decreases hepatic ischemia/reperfusion injury.
Lee LY; Harberg C; Matkowskyj KA; Cook S; Roenneburg D; Werner S; Johnson DA; Johnson JA; Foley DP
Liver Transpl; 2016 Aug; 22(8):1115-28. PubMed ID: 27113842
[TBL] [Abstract][Full Text] [Related]
16. Exosomes Derived from Dendritic Cells Attenuate Liver Injury by Modulating the Balance of Treg and Th17 Cells After Ischemia Reperfusion.
Zheng L; Li Z; Ling W; Zhu D; Feng Z; Kong L
Cell Physiol Biochem; 2018; 46(2):740-756. PubMed ID: 29621784
[TBL] [Abstract][Full Text] [Related]
17. Vildagliptin Attenuates Hepatic Ischemia/Reperfusion Injury via the TLR4/NF-
Sherif IO; Al-Shaalan NH
Oxid Med Cell Longev; 2018; 2018():3509091. PubMed ID: 30405876
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from TGF-β1-pretreated mesenchymal stem cells alleviate biliary ischemia-reperfusion injury through Jagged1/Notch1/SOX9 pathway.
Yasen A; Feng J; Xie XM; Li K; Cai YH; Liao ZH; Liang RB; Dai TX; Wang GY
Int Immunopharmacol; 2023 Jun; 119():110253. PubMed ID: 37156030
[TBL] [Abstract][Full Text] [Related]
19. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
20. Downregulated microRNA-330 suppresses left ventricular remodeling via the TGF-β1/Smad3 signaling pathway by targeting SRY in mice with myocardial ischemia-reperfusion injury.
Liu ZY; Pan HW; Cao Y; Zheng J; Zhang Y; Tang Y; He J; Hu YJ; Wang CL; Zou QC; Fu QH; Zhang L; Peng JQ; Ling J; Peng N; Rong JJ; Zheng ZF
J Cell Physiol; 2019 Jul; 234(7):11440-11450. PubMed ID: 30548582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
